analyst
CR
NASDAQ · CRVO
CervoMed Inc.
Healthcare · Biotechnology
$2.67
Up+$0.07 (+2.56%)
Updated Sep 29, 2026, 3:10 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 76.61M
- P/E ratio
- -3.28
- Dividend yield
- 0.00%
- 52-week range
- $2.13 – $10.00
- Volume
- 170.91K
- Avg. volume
- 91.54K
Price performance · CRVO
CRVO price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 28, 2026
CRVO closed at $2.67 after 20 trading sessions, up 1.52% for the selected period.
- Last close
- $2.67
- Period change
- +1.52%
- Period low
- $2.41
- Period high
- $2.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | $2.55 | $2.68 | $2.54 | $2.67 | 170.91K |
| Sep 25, 2026 | $2.52 | $2.63 | $2.52 | $2.54 | 106.09K |
| Sep 24, 2026 | $2.46 | $2.53 | $2.43 | $2.52 | 91.01K |
| Sep 23, 2026 | $2.59 | $2.60 | $2.50 | $2.51 | 123.58K |
| Sep 22, 2026 | $2.43 | $2.61 | $2.42 | $2.53 | 260.73K |
| Sep 21, 2026 | $2.47 | $2.49 | $2.41 | $2.41 | 109.1K |
| Sep 18, 2026 | $2.53 | $2.5754 | $2.43 | $2.43 | 180.86K |
| Sep 17, 2026 | $2.53 | $2.6007 | $2.48 | $2.55 | 119.43K |
| Sep 16, 2026 | $2.45 | $2.5192 | $2.40 | $2.44 | 100.33K |
| Sep 15, 2026 | $2.53 | $2.53 | $2.43 | $2.45 | 106.98K |
| Sep 14, 2026 | $2.54 | $2.58 | $2.49 | $2.53 | 128.3K |
| Sep 11, 2026 | $2.54 | $2.6396 | $2.50 | $2.57 | 234.57K |
| Sep 10, 2026 | $2.50 | $2.53 | $2.47 | $2.48 | 114.86K |
| Sep 9, 2026 | $2.53 | $2.54 | $2.47 | $2.51 | 156.01K |
| Sep 8, 2026 | $2.58 | $2.58 | $2.4199 | $2.53 | 393.94K |
| Sep 4, 2026 | $2.54 | $2.58 | $2.52 | $2.56 | 108.6K |
| Sep 3, 2026 | $2.66 | $2.665 | $2.52 | $2.54 | 199.04K |
| Sep 2, 2026 | $2.55 | $2.65 | $2.55 | $2.64 | 134.53K |
| Sep 1, 2026 | $2.58 | $2.67 | $2.55 | $2.57 | 183.58K |
| Aug 31, 2026 | $2.56 | $2.64 | $2.55 | $2.63 | 95K |
Latest CRVO news
The latest Smart Investors Daily articles mentioning CRVO.
Stock researchResearch & News · Analysis
Loading stock research…

